| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | PAYP | Japan | $17.45 | $0.00 | Buy | 9 | 2026 |
#2 | GENB | United States | $12.25 | $0.00 | Strong Buy | 6 | N/A |
#3 | FLYW | United States | $14.30 | $623,025,000.00 | Buy | 14 | 2021 |
#4 | VRRM | United States | $4.10 | $132,969,000.00 | Buy | 5 | 2016 |
#5 | DEC | United States | $14.20 | $1,829,142,000.00 | Strong Buy | 8 | 2022 |
#6 | TBPH | United States | $15.72 | $15,386,000.00 | Buy | 6 | 2013 |
#7 | EYE | United States | $15.82 | $1,987,488,000.00 | Strong Buy | 9 | 2017 |
#8 | OOMA | United States | $16.61 | $114,490,000.00 | Strong Buy | 4 | 2015 |
#9 | NTST | United States | $19.70 | $195,006,000.00 | Strong Buy | 14 | 2020 |
#10 | DCTH | United States | $10.31 | $0.00 | Strong Buy | 4 | 2015 |
#11 | ALHC | United States | $14.19 | $3,948,719,000.00 | Buy | 8 | 2021 |
#12 | NMRK | United States | $13.88 | $3,294,024,000.00 | Buy | 5 | 2017 |
#13 | OMER | United States | $10.02 | $29,868,000.00 | Strong Buy | 5 | 2008 |
#14 | AVTX | United States | $14.58 | $27,813,137.00 | Strong Buy | 8 | 2015 |
#15 | SHC | United States | $14.96 | $1,163,617,000.00 | Buy | 7 | 2020 |
#16 | NRDS | United States | $8.17 | $836,600,000.00 | Buy | 5 | 2021 |
#17 | AMLX | United States | $13.40 | $380,786,000.00 | Strong Buy | 9 | 2021 |
#18 | ARVN | United States | $7.79 | $262,600,000.00 | Buy | 19 | 2018 |
#19 | STTK | United States | $4.92 | $1,000,000.00 | Buy | 7 | 2020 |
#20 | IMNM | United States | $19.28 | $6,941,000.00 | Strong Buy | 10 | 2020 |
#21 | CRVS | United States | $11.59 | $0.00 | Strong Buy | 6 | 2016 |
#22 | RLMD | United States | $6.34 | $13,070.00 | Strong Buy | 5 | 2012 |
#23 | INGN | United States | $6.11 | $348,668,000.00 | Strong Buy | 4 | 2013 |
#24 | PHAT | United States | $9.67 | $175,110,000.00 | Strong Buy | 6 | 2019 |
#25 | LXEO | United States | $4.50 | $654,000.00 | Strong Buy | 9 | 2023 |
#26 | IBRX | United States | $7.07 | $113,288,000.00 | Strong Buy | 7 | 2015 |
#27 | TARA | United States | $4.34 | $2,948,000.00 | Strong Buy | 5 | 2014 |
#28 | IMRX | United States | $4.40 | $0.00 | Strong Buy | 5 | 2021 |
#29 | ERAS | United States | $13.10 | $0.00 | Strong Buy | 12 | 2021 |
#30 | OBIO | United States | $3.89 | $33,482,000.00 | Strong Buy | 5 | 2020 |
#31 | SBH | United States | $12.12 | $3,701,424,000.00 | Buy | 6 | 2006 |
#32 | TRVI | United States | $13.47 | $0.00 | Strong Buy | 11 | 2019 |
#33 | ADCT | Switzerland | $3.14 | $81,357,000.00 | Strong Buy | 4 | 2019 |
#34 | ENTA | United States | $11.97 | $102,814,000.00 | Strong Buy | 5 | 2012 |
#35 | OFIX | United States | $9.79 | $822,312,000.00 | Buy | 5 | 1998 |
#36 | FHTX | United States | $3.68 | $30,909,000.00 | Strong Buy | 8 | 2020 |
#37 | RVLV | United States | $18.52 | $1,225,682,000.00 | Buy | 12 | 2018 |
#38 | CVRX | United States | $5.46 | $56,651,000.00 | Buy | 4 | 2021 |
#39 | FNB | United States | $17.14 | $0.00 | Strong Buy | 5 | 2002 |
#40 | ORIC | United States | $7.45 | $0.00 | Strong Buy | 13 | 2020 |
#41 | SBRA | United States | $18.43 | $774,632,000.00 | Buy | 8 | 2010 |
#42 | VSTM | United States | $3.72 | $30,914,000.00 | Strong Buy | 7 | 2011 |
#43 | VIR | United States | $8.86 | $68,556,000.00 | Strong Buy | 7 | 2019 |
#44 | OLMA | United States | $10.57 | $0.00 | Strong Buy | 10 | 2020 |
#45 | SNDX | United States | $18.24 | $172,352,000.00 | Strong Buy | 13 | 2014 |
#46 | DBVT | France | $17.92 | $5,636,000.00 | Buy | 7 | 2014 |
#47 | TSHA | United States | $5.58 | $9,773,000.00 | Strong Buy | 8 | 2020 |
#48 | FWRG | United States | $10.27 | $1,222,501,000.00 | Strong Buy | 13 | 2021 |
#49 | CTNM | United States | $12.58 | $0.00 | Buy | 4 | 2024 |
#50 | CTMX | United States | $3.24 | $76,201,000.00 | Strong Buy | 10 | 2015 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $20 to Buy (June 3, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.